Tencent backed VoxelCloud secures USD 15M for AI medical technology beyond hospitals, & more

Medical AI startup VoxelCloud receives USD 15M for Series A+


Founder: Ding Xiaowei

Founded in: 2016

Financing status: RMB 100 million (USD 15 million) for Series A+ financing in 2017

Medical artificial intelligence startup, VoxelCloud, received USD 15 million for Series A+ on September 28 to expand its AI-assisted medical solutions beyond hospitals, as well as to promote innovations in medical AI technology.

VoxelCloud is a medical artificial intelligence startup that develops products that bring AI to the healthcare industry to provide accessible diagnoses, and accurate and personalized medical solutions for doctors and patients. Its services include automated medical image analysis algorithms and end-to-end solutions that help doctors make clinical decisions in a more accurate, accessible, and efficient way. It covers lung cancer, retinal diseases, and coronary heart disease.

Founded in 2016 in Shenzhen, it has set up offices in LA, Shanghai, and Suzhou. VoxelCloud’s CT Image Analysis product line has obtained FDA and CE approval for clinical use. In China, VoxelCloud has also submitted five products for CFDA approval, and some of the products are expected to be cleared by the end of this year. Its products have been applied by over 50 hospitals and have helped doctors to diagnose over 50,000 patients with chest diseases, over 50,000 patients with heart disease, and over 100,000 patients with retinal diseases, according to its founder, Ding Xiaowei.

This new financing round was led by Tencent, a Chinese tech giant, with existing investors including Sequoia and Newmargin participating. The capital will be used to expand its AI-assisted medical solutions to more areas, as well as to promote innovations in medical AI technology.

Photo from 699pic.com

Medical service platform Jijiankang receives USD 9M for angel round


Founder: Wu Yong

Founded in: 2017

Financing status: RMB 60 million (USD 9 million) for angel round financing in 2017

Medical service platform, Jijiankang, received USD 9 million for angel round financing to invest in the development of big data and artificial intelligence technologies to boost its services.

Jijiankang is a medical service platform that provides hospitals and users with health management and medical services based on big data. It collects data from physical examinations through a variety of medical data and vital signs to establish complete health profiles. Additionally, the company can offer disease risk assessment based on its database. It also provides users with accurate health management and follow-up medical services for a whole life-cycle based on the integration of big data and AI technology.

Founded in 2017 in Beijing, it has formed partnerships with more than 2000 doctors to apply its platform to medical treatments, as well as work with other AI companies to build a database for the health industry. Meanwhile, more than 300 enterprises have introduced its medical services to its employees. According to the founder, Wu Yong, Jijiankang is seeking cooperation with more than 1000 physical examination organizations to promote its platform.

This angel round financing was from a group of investors, including the founder of Ciming Checkup, Doctor Han Xiaohong, Tianyi Group, and Beijing Zhisland Investment Management Co., Ltd, among others. Jijiankang plans to use the funds to invest in the development of big data and artificial intelligence technologies to boost its services, as well as seek opportunities to attract more partners and users.

(Top photo from 699pic.com)

Kaikai Shi

Kaikai Shi writes for us. He holds a bachelor's degree in Biotechnology at Zhejiang University. His interests are in new technology and reading. Kai believes that new technology will change the world we live in, and is trying to engage himself in this process.

© 2022 All Tech Asia. All Rights Reserved.

AllTechAsia is a startup media platform dedicated to providing the hottest news, data service and analysis on the tech and startup scene of Asian markets in English. Contact us: info@alltechasia.com

%d bloggers like this: